BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Executive Officer Management Changes SEC β€” February 03, 2026

USA Executive & Director Changes

34 high priority34 total filings analysed

Executive Summary

On February 4, 2026, an unprecedented 34 US companies filed 8-Ks disclosing executive and director changes under Item 5.02, spanning finance (7 filings), tech/AI/software (7), biotech/pharma (5), consumer/food/industrials (7), energy/mining (4), REITs (2), and others, signaling a potential systemic wave of leadership churn possibly tied to earnings season or market pressures. Uniform neutral sentiment across all filings, with materiality averaging 5/10 (range 3-8/10) and risk levels mostly low-medium, but critical lack of details on positions, individuals, reasons, departures vs appointments, and no enriched quantitative data (YoY/QoQ trends, insider trades, capital allocation, forward-looking guidance) disclosed, amplifying uncertainty. 17/34 include Item 7.01 Reg FD disclosures suggesting attached press releases in exhibits for deeper insights; 6 pair with Item 2.02 results of operations. Portfolio-level implications: elevated governance risk in finance/tech sectors (14/34 filings), potential for strategic resets but watch for CEO/CFO specifics in follow-ups. No period-over-period trends available due to non-disclosure, but cluster suggests sector rotation or instability; highest materiality in AquaBounty (8/10, +Item 5.01 control change), Brookfield/Laser Photonics (7/10). Actionable now: scan exhibits for names/roles, avoid new positions until details emerge.

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 02, 2026.

Investment Signals(12)

  • Item 5.01 change in control paired with Item 5.02 officer change, materiality 8/10 highest in stream, signals potential activist/investor-driven refresh

  • Item 5.02 + Item 2.02 results disclosure, materiality 7/10, asset mgmt stability amid leadership shift

  • Item 5.02 + Item 7.01 Reg FD, materiality 7/10 medium-high, tech firm potential for innovative leadership hire

  • Item 5.02 + Item 5.03 bylaws amendment, noted opportunities in succession/governance enhancements

  • Explicit opportunities in positive succession planning if appointment, medium materiality 5/10

  • β–²

    Medium materiality 6/10 officer change, low quantitative disclosure but potential for growth-stage pivot

  • β–²

    AI sector peer with Item 5.02, medium risk but leadership refresh amid hot sector

  • β–²

    Item 5.02 + Item 2.02 results, cybersecurity firm low risk 5/10 materiality signals operational continuity

  • Item 5.02 + Item 2.02 results, medium materiality 6/10 in high-growth tech, routine change

  • β–²

    Medium risk/materiality 6/10, energy sector officer change lacks details signaling potential volatility

  • β–²

    Item 5.02 + Item 7.01, medium risk 5/10 undisclosed details in volatile energy

  • β–²

    Software firm Item 5.02 low materiality 4/10 but lack of details raises minor flags

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Finance/Banking Churn
    β—†

    7/34 filings (Midland, ChoiceOne, WaFd, Piper Sandler, USCB, Kinsale, Evercore), avg materiality 4.5/10 medium risk, lack of details signals potential deposit/regulatory pressures; avoid sector longs until CEO/CFO clarity

  • Tech/AI/Software Wave
    β—†

    7/34 (Lam Research, Uber, PagerDuty, Global AI, Rubrik, Laser Photonics), avg materiality 5.5/10, many with Reg FD/Item 2.02, leadership refresh amid AI boom but disclosure gaps flag execution risks

  • Biotech/Pharma Instability
    β—†

    5/34 (FuelCell note: energy but bio-adj, Aligos, Lipella, AquaBounty, TransMedics), avg materiality 6/10 highest risk cluster, control change in AquaBounty outlier; high volatility opportunity post-turnover

  • Consumer/Industrials Routine
    β—†

    7/34 (Lamb Weston, Freshpet, United Rentals, Krispy Kreme, Middleby, Asbury Auto), avg low materiality 4/10 low risk, suggests planned successions vs distress

  • Energy/Mining Governance Flags
    β—†

    4/34 (FuelCell, NRG, i-80 Gold, Cadiz/Envirotech adj), medium risk avg 5/10, undisclosed changes amid commodity swings

  • REIT Leadership Shifts
    β—†

    2/34 (COPT Defense, American Healthcare), medium materiality 5.5/10 + Reg FD, potential for yield plays if appointments strengthen capital allocation

Watch List(8)

Filing Analyses(34)
Lamb Weston Holdings, Inc.8-Kneutralmateriality 3/10

04-02-2026

Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.

LAM RESEARCH CORP8-K/Aneutralmateriality 3/10

04-02-2026

LAM Research Corp filed an 8-K on February 4, 2026 (AccNo: 0000707549-26-000014), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

Midland States Bancorp, Inc.8-Kneutralmateriality 3/10

04-02-2026

Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

Uber Technologies, Inc8-Kneutralmateriality 6/10

04-02-2026

Uber Technologies, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or financial metrics are disclosed. The filing size is 696 KB with AccNo 0001543151-26-000011.

FUELCELL ENERGY INC8-Kneutralmateriality 6/10

04-02-2026

FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

Freshpet, Inc.8-Kneutralmateriality 4/10

04-02-2026

Freshpet, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

UNITED RENTALS, INC.8-Kneutralmateriality 5/10

04-02-2026

UNITED RENTALS, INC. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

Brookfield Asset Management Ltd.8-Kneutralmateriality 7/10

04-02-2026

Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.

PIPER SANDLER COMPANIES8-Kneutralmateriality 4/10

04-02-2026

Piper Sandler Companies filed an 8-K on 2026-02-04 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

NRG ENERGY, INC.8-Kneutralmateriality 5/10

04-02-2026

NRG Energy, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

CHOICEONE FINANCIAL SERVICES INC8-Kneutralmateriality 4/10

04-02-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on 2026-02-04 related to an officer change, including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the key position affected, whether it is an appointment or resignation, reason for the change, timing, or any named executives are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or governance implications are mentioned.

  • Β·AccNo: 0000905729-26-000032
  • Β·File Size: 5 MB
  • Β·Event Type: Officer Change
  • Β·Item 5.02 (typical for officer changes) not explicitly listed
MSC INCOME FUND, INC.8-Kneutralmateriality 4/10

04-02-2026

MSC Income Fund, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

  • Β·Filing AccNo: 0001535778-26-000016
  • Β·File size: 294 KB
  • Β·Sector: not specified
i-80 Gold Corp.8-Kneutralmateriality 5/10

04-02-2026

i-80 Gold Corp. filed an 8-K on 2026-02-04 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any financial metrics are disclosed in the provided filing information.

WAFD INC8-Kneutralmateriality 4/10

04-02-2026

WAFD INC filed an 8-K on 2026-02-04 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, such as key positions affected, appointment or resignation reasons, board meeting outcomes, or quantitative metrics, are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

  • Β·AccNo: 0000936528-26-000023
  • Β·File Size: 209 KB
  • Β·Sector: NOT_DISCLOSED
ALT5 Sigma Corp8-Kneutralmateriality 6/10

04-02-2026

ALT5 Sigma Corp filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts were disclosed.

Global AI, Inc.8-Kneutralmateriality 6/10

04-02-2026

Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

Lifevantage Corp8-Kneutralmateriality 5/10

04-02-2026

Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.

Aligos Therapeutics, Inc.8-Kneutralmateriality 6/10

04-02-2026

Aligos Therapeutics, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037558, Size: 137 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative metrics are provided. This is a routine SEC-required disclosure for material leadership events with no additional context available.

  • Β·Filing Accession Number: 0001193125-26-037558
  • Β·Filing Size: 137 KB
  • Β·Event Date: 2026-02-04
  • Β·Sector: NOT_DISCLOSED
PagerDuty, Inc.8-Kneutralmateriality 4/10

04-02-2026

PagerDuty, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected position, individual name, appointment or resignation, reasons, or timing are NOT_DISCLOSED.

AQUABOUNTY TECHNOLOGIES INC8-K/Aneutralmateriality 8/10

04-02-2026

AquaBounty Technologies Inc. filed an 8-K on 2026-02-04 disclosing Item 5.01 Changes in Control of Registrant and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or compensatory terms are disclosed. No financial metrics, performance data, or quantitative information provided.

LIPELLA PHARMACEUTICALS INC.8-Kneutralmateriality 5/10

04-02-2026

Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.

TransMedics Group, Inc.8-Kneutralmateriality 3/10

04-02-2026

TransMedics Group, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.

Kinsale Capital Group, Inc.8-Kneutralmateriality 5/10

04-02-2026

Kinsale Capital Group, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on affected positions, individuals, reasons, or impacts are disclosed.

COPT DEFENSE PROPERTIES8-Kneutralmateriality 5/10

04-02-2026

COPT DEFENSE PROPERTIES filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason, timing, or any quantitative data are disclosed.

Krispy Kreme, Inc.8-Kneutralmateriality 3/10

04-02-2026

Krispy Kreme, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or implications are disclosed. This is a routine disclosure with no quantitative metrics, positive or negative changes reported.

USCB FINANCIAL HOLDINGS, INC.8-Kneutralmateriality 5/10

04-02-2026

USCB Financial Holdings, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for change, or quantitative data are disclosed.

American Healthcare REIT, Inc.8-Kneutralmateriality 6/10

04-02-2026

American Healthcare REIT, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

  • Β·Filing accession number: 0001193125-26-037696
  • Β·Filing size: 214 KB
ASBURY AUTOMOTIVE GROUP INC8-Kneutralmateriality 6/10

04-02-2026

Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.

MIDDLEBY Corp8-Kneutralmateriality 4/10

04-02-2026

Middleby Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative impacts are disclosed.

Rubrik, Inc.8-Kneutralmateriality 5/10

04-02-2026

Rubrik, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons, timing, financial metrics, or quantitative data are disclosed. Sector is not specified.

Evercore Inc.8-Kneutralmateriality 3/10

04-02-2026

Evercore Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.

Laser Photonics Corp8-Kneutralmateriality 7/10

04-02-2026

Laser Photonics Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, appointment or resignation status, reasons for change, and any governance implications are NOT_DISCLOSED.

CADIZ INC8-Kneutralmateriality 3/10

04-02-2026

Cadiz Inc filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any financial metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no additional quantitative or qualitative context provided.

Envirotech Vehicles, Inc.8-Kneutralmateriality 5/10

04-02-2026

Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 34 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Executive Officer Management Changes SEC β€” February 03, 2026 | Gunpowder Blog